1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Parmax Pharma
Parmax Pharma Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Parmax Pharma Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
83.74% Gain from 52W Low
10.7
Dividend yield 1yr %
0
Parmax Pharma Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
44.70
10Day EMA
44.50
12Day EMA
44.40
20Day EMA
44.00
26Day EMA
43.80
50Day EMA
43.30
100Day EMA
42.80
200Day EMA
41.10
5Day SMA
44.80
10Day SMA
44.20
20Day SMA
43.90
30Day SMA
43.40
50Day SMA
42.70
100Day SMA
43.00
150Day SMA
43.70
200Day SMA
42.00
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 533 Rs | 571 Rs |
Week Rs | 566 Rs | 834 Rs |
Month Rs | 579 Rs | 839 Rs |
Resistance & Support
44.40
Pivot
Resistance
First Resistance
49.39
Second Resistance
52.80
Third Resistance
57.79
Support
First Support
40.99
Second support
36.00
Third Support
32.59
Relative Strength Index
54.26
Money Flow Index
61.83
MACD
0.60
MACD Signal
0.56
Average True Range
3.80
Average Directional Index
13.03
Rate of Change (21)
13.28
Rate of Change (125)
2.31
Similar stocks
Similar Stocks
Peer comparison
Compare
| Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
17.21 | 25.03 | 54 | 42.02 | 2.20% | 8.88% | -0.13% | 53.30% | 9.63% | 0.00% | 0.00 | 40.74 | -21.26 | ||
Chemo Pharma Laboratories Ltd. | 131.30 | - | - | - | - | - | - | - | - | - | - | - | - | |
Phaarmasia Ltd. | 30.20 | - | - | - | - | - | - | - | - | - | - | - | - | |
Venmax Drugs & Pharmaceuticals Ltd. | 27.90 | - | - | - | - | - | - | - | - | - | - | - | - | |
Checkpoint Trends Ltd. | 27.76 | - | - | - | - | - | - | - | - | - | - | - | - | |
Norris Medicines Ltd. | 16.65 | - | - | - | - | - | - | - | - | - | - | - | - | |
Sunrest Lifescience Ltd. | 55.00 | - | - | - | - | - | - | - | - | - | - | - | - |
Parmax Pharma Company background
Founded in: 1994
Managing director: Umang Alkesh Gosalia
Incorporated in Nov.94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmaxs pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc. The Company then discontinued their business activities for few years due to various reasons. Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994 the Company had set up a plant to manufacture and market bulk drugs like amoxycillin trihydrate, ampicillin trihydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA. Antibiotic project was fully implemented from 31st May97.
Parmax Pharma FAQs
How to buy Parmax Pharma shares?
You can easily buy Parmax Pharma shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Parmax Pharma stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account
